Chapter 2: Biomedical Literature Mining, Experimental Study Design & Statistical Power

1. Experimental Study Design in Transcriptomics

No computational algorithm, batch correction model, or advanced machine learning classifier can rescue an RNA-Seq experiment crippled by a fundamentally flawed experimental design. Before sequencing a single cell or tissue biopsy, researchers must rigorously formulate their hypothesis and establish sufficient replication to distinguish genuine biological perturbation from stochastic noise.

2. Avoiding Fatal Confounding & Batch Effects

A batch effect occurs when non-biological experimental factors—such as isolation date, library preparation kit lot, RNA extraction technician, or sequencing flowcell—correlate with the biological conditions under investigation. If all Control samples are extracted on Monday by Technician A and sequenced on Flowcell 1, while all Drug-Treated samples are extracted on Friday by Technician B and sequenced on Flowcell 2, the experiment is completely confounded. It is mathematically impossible to determine whether observed differential expression stems from the therapeutic compound or reagent lot variation.

3. Statistical Power Calculation with RNASeqPower

Determining how many biological replicates are required to detect a specified fold change depends on three critical parameters:

1. Biological Coefficient of Variation (BCV): The dispersion \(\alpha\) across biological replicates. For genetically identical inbred mouse or cell line experiments, \(\text{BCV} \approx 0.1 - 0.2\). For human clinical tumor biopsies or outbred human patient cohorts, \(\text{BCV} \approx 0.4 - 0.6\).
2. Sequencing Depth: Average read count per transcript. Beyond 20–30 million reads per sample in bulk mammalian RNA-Seq, statistical power gains plateau; investing resources into additional biological replicates yields dramatically greater power than increasing sequencing depth to 60+ million reads.
3. Target Effect Size: Desired minimum fold change (\(\Delta = 1.5\) or \(2.0\)) and False Discovery Rate (\(\alpha = 0.05\)).

Reproducible R Power Calculation Script

# Install RNASeqPower if not present
if (!requireNamespace("RNASeqPower", quietly = TRUE)) {
    BiocManager::install("RNASeqPower")
}
library(RNASeqPower)
library(ggplot2)

# Parameters:
# n = sample size per group (ranging from 3 to 12)
# depth = average read count per gene (e.g. 20 reads)
# cv = biological coefficient of variation (0.4 for clinical human cohorts)
# effect = fold change (1.5x and 2.0x)
# alpha = significance threshold after FDR (0.05)

sample_sizes <- seq(3, 15, by = 1)

power_fc2 <- rnapower(
    depth = 20,
    n = sample_sizes,
    cv = 0.4,
    effect = 2.0,
    alpha = 0.05
)

power_fc1_5 <- rnapower(
    depth = 20,
    n = sample_sizes,
    cv = 0.4,
    effect = 1.5,
    alpha = 0.05
)

power_df <- data.frame(
    Sample_Size = rep(sample_sizes, 2),
    Power = c(power_fc2, power_fc1_5),
    Effect_Size = rep(c("Fold Change = 2.0 (log2FC = 1.0)", "Fold Change = 1.5 (log2FC = 0.58)"), each = length(sample_sizes))
)

# Plotting Statistical Power Curve
ggplot(power_df, aes(x = Sample_Size, y = Power, color = Effect_Size)) +
    geom_line(linewidth = 1.2) +
    geom_point(size = 3) +
    geom_hline(yintercept = 0.80, linetype = "dashed", color = "red") +
    annotate("text", x = 5, y = 0.83, label = "Standard Power Benchmark (80%)", color = "red", fontface = "bold") +
    scale_y_continuous(limits = c(0, 1.0), breaks = seq(0, 1, 0.1)) +
    scale_x_continuous(breaks = sample_sizes) +
    scale_color_manual(values = c("#06b6d4", "#f43f5e")) +
    labs(
        title = "RNA-Seq Statistical Power Curve (Human Clinical Cohort, BCV = 0.4)",
        subtitle = "Demonstrating that n >= 6 biological replicates is required to detect 1.5-fold biological shifts",
        x = "Biological Replicates Per Experimental Arm (n)",
        y = "Statistical Power (1 - Beta)",
        color = "Target Effect Size"
    ) +
    theme_minimal(base_size = 14) +
    theme(legend.position = "bottom")